Are Cashews Bad for Fatty Liver?

Cashews and fatty liver disease is a question worth exploring carefully, as dietary choices play a central role in managing this increasingly common condition. Cashews are not bad for fatty liver disease and, eaten in moderate amounts as part of a balanced diet, may offer genuine nutritional benefits. Rich in unsaturated fats, magnesium, plant protein, and antioxidants, cashews compare favourably with many processed snack foods. However, they are not a treatment, and overall dietary quality, energy balance, and gradual weight loss remain the key drivers of improvement in metabolic dysfunction-associated steatotic liver disease (MASLD).

Are cashews bad for fatty liver, or can they actually help?

Cashews are not bad for fatty liver disease and may be beneficial in moderate amounts, as they provide unsaturated fats, magnesium, and antioxidants. They are not a treatment; overall dietary quality and gradual weight loss remain the primary management strategies.

Cashews are not bad for fatty liver disease and, when eaten in moderate amounts as part of a balanced diet, may offer nutritional benefits relevant to liver health. Fatty liver disease, whether alcohol-related (ALD) or metabolic dysfunction-associated steatotic liver disease (MASLD, previously called non-alcoholic fatty liver disease or NAFLD, a term still used on many NHS pages), is strongly influenced by overall dietary quality, and cashews compare favourably with many common snack foods.

Cashews are a source of unsaturated fats, plant protein, magnesium, and antioxidant compounds, all of which have been associated with reduced metabolic risk in the broader nutrition literature. Unlike ultra-processed snacks high in saturated fat, refined sugar, or salt, cashews provide a nutrient-dense alternative that fits within dietary patterns recommended for metabolic health.

It is important to be clear that cashews are not a treatment for fatty liver disease. The key drivers of improvement in MASLD are overall energy balance, gradual weight loss, and a healthy dietary pattern as a whole. Evidence for cashews specifically is limited; most research has examined nuts as a food group, or particular varieties such as walnuts, rather than cashews in isolation. The question is therefore not whether cashews are harmful in principle, but whether they are eaten in appropriate quantities and as part of a broader healthy eating pattern.

For most people with fatty liver disease who do not have a nut allergy or specific dietary restriction, moderate cashew consumption is unlikely to be harmful and may be beneficial as part of a varied diet. If you have been diagnosed with liver disease and are uncertain about your diet, speaking to your GP or a registered dietitian is the most appropriate first step. They can tailor dietary advice to your individual circumstances, including any co-existing conditions such as type 2 diabetes or obesity.

What does the evidence say about nuts and liver health?

Regular nut consumption is associated with lower rates of MASLD and improved liver enzyme levels in observational studies and meta-analyses. Most evidence covers nuts as a group rather than cashews specifically, and randomised trials remain limited.

Research consistently suggests that regular nut consumption is associated with a lower risk of metabolic liver disease and improved liver enzyme profiles. A number of observational studies and dietary intervention trials have found that people who eat nuts more frequently tend to have lower rates of MASLD and better markers of liver function, including alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels.

A large prospective cohort study published in the journal Gut found that higher nut intake was inversely associated with the risk of NAFLD, even after adjusting for other lifestyle factors. Systematic reviews and meta-analyses examining nut consumption and liver outcomes have broadly supported this association, though the quality and design of individual studies vary.

While much of the research on nuts and liver health has focused on walnuts, which are particularly rich in alpha-linolenic acid (ALA), a plant-based omega-3 fatty acid, cashews share several beneficial properties, including unsaturated fat content and antioxidant compounds.^[4] It is important to note that ALA from plant sources is not equivalent to the long-chain marine omega-3 fatty acids (EPA and DHA) found in oily fish.^[4]

Most studies in this area are observational, meaning they identify associations rather than proving direct causation. Randomised controlled trials specifically examining cashews and liver fat are limited, and the evidence base for nuts as a whole, while encouraging, should be interpreted with appropriate caution. Nuts are most likely to benefit liver health when they replace less healthy foods, such as processed snacks or foods high in saturated fat, rather than being added on top of an already high-calorie diet.

The broader Mediterranean dietary pattern, which includes regular nut consumption alongside olive oil, vegetables, legumes, and fish, has a strong evidence base for reducing liver fat and improving metabolic health, supported by clinical practice guidelines from bodies including the European Association for the Study of the Liver (EASL) and the British Society of Gastroenterology (BSG). Cashews can reasonably form part of this pattern.

Which nutrients in cashews affect a fatty liver?

Cashews contain unsaturated fats, magnesium, plant protein, antioxidants, and fibre, all of which support metabolic health relevant to fatty liver. Salted varieties should be avoided, particularly in advanced liver disease, due to high sodium content.

Several specific nutrients found in cashews are relevant to liver health, and understanding their roles helps explain why moderate cashew consumption may be beneficial rather than harmful.

Unsaturated fats: Cashews contain predominantly monounsaturated and polyunsaturated fats. Replacing saturated fats with unsaturated fats is a well-established dietary strategy for improving metabolic health, and dietary guidelines for MASLD, including those from EASL and the BSG, support reducing saturated fat intake in favour of unsaturated fat sources. These fats have been associated with reduced hepatic fat accumulation and improved insulin sensitivity, both of which are central to managing MASLD.

Magnesium: Cashews are one of the better dietary sources of magnesium. Low magnesium status has been associated with insulin resistance and markers of liver inflammation in observational research, both of which contribute to the progression of fatty liver disease. Adequate magnesium intake may therefore support metabolic health indirectly, though this relationship requires further study.

Plant protein: The protein content of cashews contributes to satiety and helps preserve lean muscle mass, which is important during weight management. Gradual, sustained weight loss is one of the most effective interventions for reducing liver fat in MASLD.

Antioxidants: Cashews contain tocopherols (a form of vitamin E) and other antioxidant compounds. Oxidative stress is thought to play a role in the progression of fatty liver to more advanced stages such as metabolic-associated steatohepatitis (MASH), and antioxidant-rich foods may help mitigate this process, though evidence from trials of vitamin E supplementation in MASLD has produced mixed results and supplementation is not routinely recommended outside specialist care.^[7][8]

Fibre: Although cashews contain less fibre than some other nuts, they still contribute to overall dietary fibre intake, which supports gut health and may reduce systemic inflammation relevant to liver disease.

One nutrient to be mindful of is sodium. Salted or flavoured cashew products can be high in salt. Limiting salt intake is particularly important for people with more advanced liver disease, such as cirrhosis with fluid retention (ascites), in line with NICE guidance on cirrhosis (NG50). Choosing unsalted, unflavoured varieties is advisable for anyone with liver disease.

How many cashews is it safe to eat each day with liver disease?

Around 30g of unsalted cashews daily (roughly 15 to 18 nuts, providing 160 to 170 kcal) is a reasonable portion for most adults with fatty liver disease. People with cirrhosis or complex needs should seek advice from a hepatologist or specialist dietitian.

A daily portion of around 30 grams of unsalted cashews, which is roughly a small handful or approximately 15 to 18 nuts, is a reasonable amount for most adults with fatty liver disease. This aligns with general guidance on nut consumption from organisations such as the British Heart Foundation and is consistent with the portion sizes used in research studies examining nut intake and metabolic health. According to UK food composition data, 30 grams of cashews provides approximately 160 to 170 kilocalories, along with useful amounts of unsaturated fat, protein, and micronutrients.^[6]

Staying within this range means you can benefit from the nutritional profile of cashews without significantly increasing your overall calorie intake, which is important given that excess calorie consumption drives hepatic fat accumulation.

For people who are actively trying to lose weight as part of managing MASLD, it is worth factoring cashews into your total daily calorie allowance rather than treating them as a free food. Even healthy foods contribute to energy intake, and portion awareness remains important.

People with more advanced liver disease, including cirrhosis, may have additional dietary considerations. It is worth noting that UK guidance, including NICE NG50 and BSG nutrition statements, emphasises that people with cirrhosis should maintain adequate protein intake to prevent muscle wasting (sarcopenia), rather than restricting protein. Protein restriction is not routinely recommended and should only be considered in specific circumstances under specialist supervision. Dietary advice for people with cirrhosis should come from a hepatologist or specialist dietitian rather than general guidance.

Practical tips for including cashews safely:

• Choose unsalted, unflavoured varieties

• Measure out a portion rather than eating directly from the packet

• Use cashews to replace less healthy snacks rather than adding them on top of existing intake

• Avoid cashew-based products with added sugar, honey, or chocolate coatings

If you are unsure how cashews fit into your individual dietary plan, your GP can refer you to a dietitian for personalised advice.

What does NHS and NICE guidance say about diet and fatty liver?

NICE NG49 recommends gradual weight loss and a Mediterranean-style diet for MASLD, which includes nuts, olive oil, vegetables, and fish. Cashews fit within this pattern, though individual dietary advice should be sought from a GP or registered dietitian.

NICE guidance on MASLD (previously NAFLD, covered in NICE guideline NG49) recommends a combination of dietary modification and increased physical activity as the cornerstone of management for most patients. NICE does not specify individual foods such as cashews, but the dietary principles it endorses are consistent with including nuts as part of a healthy eating pattern.

Key dietary recommendations from NICE and NHS guidance for people with fatty liver disease include:

• Achieving a gradual weight loss of 7 to 10 per cent of body weight, which NICE NG49 identifies as associated with significant reductions in liver fat and inflammation^[8]

• Following a healthy dietary pattern consistent with a Mediterranean style, rich in vegetables, fruit, wholegrains, legumes, fish, and unsaturated fats including nuts and olive oil; EASL and BSG guidelines provide more detailed evidence supporting this approach

• Reducing intake of saturated fat, refined carbohydrates, added sugars, and ultra-processed foods

• Limiting fructose-containing drinks and foods, including fruit juices and sugar-sweetened beverages

• Avoiding rapid or crash dieting, as sudden weight loss can paradoxically worsen liver inflammation

Regarding alcohol, UK Chief Medical Officers' low-risk drinking guidelines advise that adults drink no more than 14 units per week, spread across three or more days, with several alcohol-free days each week.^[5] For people with MASLD, reducing alcohol intake is advisable, and for those with more advanced liver disease or steatohepatitis, a specialist may recommend abstinence. If you are unsure what level of alcohol is appropriate for your situation, discuss this with your GP or hepatologist.

If you experience any of the following symptoms, seek urgent medical attention. Call 999 or go to your nearest A&E if you have vomiting blood, black or tarry stools, sudden severe confusion, or severe jaundice (yellowing of the skin or eyes) with fever or abdominal pain. Contact NHS 111 or your GP promptly for new or worsening jaundice, significant abdominal swelling, or unexplained fatigue that is getting worse.

For people seeking structured support with weight management and dietary change, a range of services are available. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where clinically appropriate options may be discussed following assessment.

If you have been diagnosed with fatty liver disease, your GP is the right starting point for accessing NHS support, including referral to hepatology, dietetics, or a structured weight management programme depending on the severity of your condition. Your GP may use non-invasive tests such as the FIB-4 score or the Enhanced Liver Fibrosis (ELF) test to assess the degree of liver scarring and determine whether specialist referral is needed, in line with NICE and BSG guidance.^[8][3]

Scientific References

1. A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
2. Understanding the evolving nomenclature of steatotic liver disease.
3. Cirrhosis in over 16s: assessment and management (NG50).
4. Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)?.
5. Alcohol consumption: advice on low risk drinking.
6. Composition of Foods Integrated Dataset (CoFID).
7. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease.
8. Metabolic dysfunction-associated steatotic liver disease (MASLD): diagnosis and management (NG49).
9. Non-alcoholic fatty liver disease (NAFLD).
10. Facts about fat.

Frequently Asked Questions